In 104 treatment-naive adults with mild-to-moderate OSA, 12 weeks of standardised orofacial myofunctional therapy did not change AHI versus waitlist (difference 0.6, 95% CI −3.3 to 4.5; P=.774); no effect on desaturation or ESS, and adherence was unrelated to AHI change.
RCTn = 104
Hansen et al. Effect of orofacial myofunctional therapy with auto-monitoring on the apnea-hypopnea index in patients with mild-to-moderate obstructive sleep apnea: a multicenter randomized controlled trial